WHO WE ARE

HISTORY

OUR JOURNEY TO
PROBIOTIC PIONEER

Since its establishment in 1995, Cell Biotech has remained steadfast in its commitment to acquiring cutting-edge probiotic technologies, embarking on a continuous journey of innovation and collaboration with hundreds of microbiologists. Through tireless efforts and numerous technological breakthroughs, we have solidified our position as a leading specialized probiotics company in Korea and beyond, demonstrating a relentless dedication to excellence in the field.

BEGINNING OF CELL BIOTECH

1999

1996

1995

Designated as a Technology Development Pilot Company (KIBO)
Designated as a Promising Export SMB (SBC)
Designated as a 50 Best Venture Company (Korea Economic Daily)

Designated as a superior technology company (KIBO)
Designated as a Venture Company (SMBA)
Acquired approval for pharmaceutical manufacturing (FDA)
Established Cell Biotech International Co., Ltd. (Establishment of sales corporation)
Completed construction of 2nd plant (end product factory - GMP Facility)

Acquired approval to produce health supplements and special nutrition foods (MOHW)
Established Cell Biotech Cell Engineering Research Institute (KOITA)
Completed construction of 1st plant (Fermentation Plant)
Awarded the Excellence Prize of Korea Industrial Technology Fair (MOTIE)
Established Cell Biotech Co., Ltd.

GROWTH AND LEAP

2008

2007

2006

Awarded the $5 Million Export Tower
Registered Dual coated lactic acid bacteria (DUOLACⓇ) patents (Europe)

Selected as a World-Class Product and World-Class Product Certification Company(MOTIE)
Awarded the Grand Prize in GS Management's Technology Management (KMAC)

Designated as ATC (Excellent Manufacturing Technology Research Center)
Awarded the $3 Million Export Tower
Visit by the Danish Prime Minister (H.E. Anders Fogh Rasmussen)
Established Cell Biotech International (Denmark)
Designated as an Innovative SMB (INNO-BIZ)

2005

Obtained GMP Certification (FDA)
Awarded the Best Practice Taxpayer Award (IRS)
Awarded the Taxpayer's Day Sincere Taxpayer 'National Tax Service' Award

2004

Awarded the $1 Million Export Tower and Prime Minister Prize (MOTIE)
Designated as a Specialized Military Service Company (MPA)
Acquired HALAL certification (KMF)
Registration of Dual coated lactic acid bacteria (DUOLACⓇ) patents (Korea, Japan)

2003

2002

2001

Designated as a World-Class Product and World-Class Product Certification Company

Listed on KOSDAQ
Obtained HACCP certification (Switzerland, SGS)
Acquired FDA Stability Certification for DUOLAC® and SAFELAC™ (USA)

Designated as a Suitable Company for Venture Business Overseas
Advancement Support Business (SMBA)

2000

Obtained BGMP Certification (FDA)
Obtained ISO-9001 Certification (UK, BM TRADA)
Awarded the 'Presidential Award' for Venture Company (MOI)
Obtained Kosher Certification (USA)

GROWTH AND LEAP

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

Completed the 4th plant (biopharmaceutical manufacturing plant)

Signed MOU with K-BIO for colorectal cancer medicine

Acquired patents for probiotics DDS (drug delivery system) and 2 types of recombinant probiotics for chemotherapy

Acquired patent for anti-cancer substance (P8) derived from probiotics

France branch established
LACTOClear® launched

Awarded the $20 Million Export Tower
Designated as a Next-Generation World-Class Product
Designated as a Top 200 Most Promising Companies in Asia (Forbes)
Designated as a Sincere Tax Paying Corporation within Gyeonggi Province

Awarded the 'Technical Award' at the 2015 International Conference and Regular Conference (Korean Society for Microbiology and Biotechnology)
Designated as 'World Class 300' (SMBA)
Designated as a 2015 Forbes Asia '200 Best Companies in Asia
Awarded the 'Chungmugong Prize' for Patent Utility (KIPO)
Awarded the 'Gold Tower Industrial Medal' during the 49th Taxpayers' Day (MOSF)

Awarded the Grand Prize during The 12th Money Today IR
Designated as a 'Best IR Company in the Small Cap category'

Completed construction of 3rd plant (end product production process) and commenced production

Registration of Active Pharmaceutical Ingredients LH(Prolac-T) and DMF
Registration of Active Pharmaceutical Ingredients LH and DMF
Renewal and Launch of DUOLAC® brand

Acquired ISO 9001 certification (UK, LRQA)
Acquired HACCP certification (UK, LRQA)
Designated as a KRX Pre-Hidden Champion

Designated as a Hidden Champion Final Candidate (Korea Eximbank)
Obtained patents on colon cancer related technologies
Awarded the Best Small Business Award (Minister of Knowledge Economy)
Awarded the Best Taxpayer Award (Minister of Strategy and Finance)
Awarded the Technology Innovation of the Year Award (Frost & Sullivan)

NOW AND FUTURE

2025

2024

2023

2022

2021

2020

Cell Biotech Launches “Stronger Probiotics, DUOLAC” Advertising Campaign

DUOLAC Achieves World’s No.1 Export Rank for 12 Consecutive Years

Cell Biotech Achieves USD 30 Million in K-Probiotics Exports to Indonesia

Colon Cancer Drug ‘PP-P8’ Enters Clinical Trials

Cell Biotech Declares 30th Anniversary Vision for Global Biopharma Innovation

DUOLAC Selected as a World-Class Product in 2024
Cell Biotech Receives OK Kosher Certification
DUOLAC Achieves World’s No.1 Export Rank for 11 Consecutive Years
Cell Biotech Donates Health Supplements Worth 300 Million KRW to Gimpo City
Colon Cancer Drug 'PP-P8' Receives Phase 1 IND Approval
DUOLAC Holds the Highest Number of GRAS Listings with the U.S. FDA

Development 'CBT-LR6 Feminine', a probiotics derived from the Korean vagina

Probiotics Exports Ranked No. 1 for 10 consecutive years

Development of protein absorption synergistic probiotics

Determining the mode of action of PP-P8, a new colorectal cancer medicine

Signed MOU with BioMe for the microbiome medicine.

Acquired a U.S.A patent for Kimchi probiotics(CBT-SL4) Drug Delivery System

Launched health food brand 'DUOLAB'

Probiotics Exports Ranked No. 1 for 9 consecutive years

Awarded as contributions to the food supplement industry (Korea Food & Drug Administration)

DUOLAC awarded 'Korea Brand Award’
(Ministry of Trade, Industry and Energy of Korea, Prime Minister’s Awards)
Designated as an excellent corporation R&D center (Ministry of Science and ICT)
'PP-P8' Microbiome Control Effect Found for the First Time
Publication in an international journal ‘Microbiome, IF=11.607’
Awarded 5th KOREA BRAND HALL OF FAME of probiotics category (IPS)

Launched 'Cellbiome' program
(Intestinal microbiological examination + Customized intestinal health care with DUOLAC)
Signed MOU with Psomagen for the commercialization of the microbiome business.

WHO WE ARE

HISTORY

OUR JOURNEY TO PROBIOTIC PIONEER

BEGINNING OF CELL BIOTECH

1999

1996

1995

HEADQUARTER

CELL BIOTECH

Address

SALES/MARKETING

CELL BIOTECH INTERNATIONAL

Address

EUROPE OFFICE

CELL BIOTECH INTERNATIONAL A/S

Address

OUR JOURNEY TO
PROBIOTIC PIONEER